Clinical Trials Browser

Interventional × Platinum-sensitive Relapsed Ovarian Cancer × Clear all

NCT06446206 2024-06-06

Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer

Phase 2 Not yet recruiting

Platinum-sensitive Relapsed Ovarian Cancer

NCT03705156 2023-04-13

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Phase 3 Unknown

Platinum-sensitive Relapsed Ovarian Cancer